X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

FATE

Closed

Fate Therapeutics Inc

1.14
+0.02 (+1.79%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.12
Day's Range: 1.1 - 1.2
Send
When Written:
 
5.7
Fate Therapeutics Inc. is a biopharmaceutical company that focuses on developing cell therapies for the treatment of cancer and other diseases. The company's proprietary platform technology, called induced pluripotent stem cell (iPSC) technology, enables the creation of cell-based therapies that can be used to treat a wide range of diseases.

Fate Therapeutics was founded in 2007 and is headquartered in San Diego, California. The company has a number of ongoing clinical trials for its cell therapies, including treatments for acute myeloid leukemia, solid tumors, and immune disorders.

In addition to its iPSC technology, Fate Therapeutics also has a number of other proprietary technologies and platforms, including gene editing and cell programming technologies. The company has partnerships with a number of other biopharmaceutical companies and research institutions to further develop its cell therapies.

Fate Therapeutics is a publicly traded company and is listed on the NASDAQ under the ticker symbol FATE.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X